Sweden
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 9.84 B |
Jan. 14, 2025 | USD 28.64 | 0.87% |
|
Sweden |
|
2 |
USD 4.53 B |
Jan. 14, 2025 | USD 16.63 | 0.49% |
|
Sweden |
|
3 |
USD 2.47 B |
Jan. 14, 2025 | USD 18.25 | 2.79% |
|
Sweden |
|
4 |
USD 2.17 B |
Jan. 14, 2025 | USD 32.97 | -0.61% |
|
Sweden |
|
5 |
USD 2.06 B |
Jan. 14, 2025 | USD 5.39 | -0.39% |
|
Sweden |
|
6 |
USD 1.79 B |
Jan. 14, 2025 | USD 3.41 | 3.24% |
|
Sweden |
|
7 |
USD 1.58 B |
Jan. 14, 2025 | USD 17.87 | 3.09% |
|
Sweden |
|
8 |
USD 1.47 B |
Jan. 14, 2025 | USD 12.08 | 1.50% |
|
Sweden |
|
9 |
USD 1.33 B |
Jan. 14, 2025 | USD 42.37 | 0.78% |
|
Sweden |
|
10 |
USD 986.08 M |
Jan. 14, 2025 | USD 9.75 | -0.95% |
|
Sweden |
|
11 |
USD 958.59 M |
Jan. 14, 2025 | USD 11.98 | -2.51% |
|
Sweden |
|
12 |
USD 705.61 M |
Jan. 14, 2025 | USD 20.58 | 0.68% |
|
Sweden |
|
13 |
USD 447.35 M |
Jan. 14, 2025 | USD 18.76 | 3.89% |
|
Sweden |
|
14 |
USD 354.31 M |
Jan. 14, 2025 | USD 31.10 | 0.68% |
|
Sweden |
|
15 |
USD 194.38 M |
Jan. 14, 2025 | USD 0.83 | 1.00% |
|
Sweden |
|
16 |
USD 190.69 M |
Jan. 14, 2025 | USD 2.91 | -2.20% |
|
Sweden |
|
17 |
USD 188.53 M |
Jan. 14, 2025 | USD 0.52 | 0.51% |
|
Sweden |
|
18 |
USD 180.59 M |
Jan. 14, 2025 | USD 2.74 | 1.67% |
|
Sweden |
|
19 |
USD 179.84 M |
Jan. 14, 2025 | USD 2.55 | 0.33% |
|
Sweden |
|
20 |
USD 167.86 M |
Jan. 14, 2025 | USD 1.61 | 0.34% |
|
Sweden |
|
21 |
USD 167.70 M |
Jan. 14, 2025 | USD 10.16 | -0.20% |
|
Sweden |
|
22 |
USD 136.78 M |
Jan. 14, 2025 | USD 2.09 | -2.04% |
|
Sweden |
|
23 |
USD 111.78 M |
Jan. 14, 2025 | USD 3.19 | 2.10% |
|
Sweden |
|
24 |
USD 105.23 M |
Jan. 14, 2025 | USD 2.83 | 5.31% |
|
Sweden |
|
25 |
USD 98.15 M |
Jan. 14, 2025 | USD 1.01 | 1.76% |
|
Sweden |
|
26 |
USD 86.16 M |
Jan. 14, 2025 | USD 2.57 | -0.02% |
|
Sweden |
|
27 |
USD 65.06 M |
Jan. 14, 2025 | USD 3.31 | 2.33% |
|
Sweden |
|
28 |
USD 59.42 M |
Jan. 14, 2025 | USD 4.99 | 0.68% |
|
Sweden |
|
29 |
USD 54.85 M |
Jan. 14, 2025 | USD 4.07 | -5.72% |
|
Sweden |
|
30 |
USD 46.91 M |
Jan. 14, 2025 | USD 0.90 | 9.88% |
|
Sweden |
|
31 |
USD 42.79 M |
Jan. 14, 2025 | USD 0.92 | -4.76% |
|
Sweden |
|
32 |
USD 38.67 M |
Jan. 14, 2025 | USD 0.83 | 0.03% |
|
Sweden |
|
33 |
USD 37.39 M |
Jan. 14, 2025 | USD 0.15 | 0.09% |
|
Sweden |
|
34 |
USD 35.90 M |
Jan. 14, 2025 | USD 0.71 | -2.02% |
|
Sweden |
|
35 |
USD 35.69 M |
Jan. 14, 2025 | USD 0.15 | -2.28% |
|
Sweden |
|
36 |
USD 35.08 M |
Jan. 14, 2025 | USD 1.88 | 0.68% |
|
Sweden |
|
37 |
USD 34.46 M |
Jan. 14, 2025 | USD 0.89 | 14.73% |
|
Sweden |
|
38 |
USD 32.89 M |
Jan. 14, 2025 | USD 0.43 | -0.78% |
|
Sweden |
|
39 |
USD 32.52 M |
Jan. 14, 2025 | USD 0.20 | 1.12% |
|
Sweden |
|
40 |
USD 31.11 M |
Jan. 14, 2025 | USD 1.60 | -0.43% |
|
Sweden |
|
41 |
USD 26.84 M |
Jan. 14, 2025 | USD 0.20 | 2.06% |
|
Sweden |
|
42 |
USD 26.22 M |
Jan. 14, 2025 | USD 0.29 | 0.68% |
|
Sweden |
|
43 |
USD 25.96 M |
Jan. 14, 2025 | USD 0.27 | -5.32% |
|
Sweden |
|
44 |
USD 25.15 M |
Jan. 14, 2025 | USD 0.12 | -10.06% |
|
Sweden |
|
45 |
USD 24.76 M |
Jan. 14, 2025 | USD 1.17 | -3.73% |
|
Sweden |
|
46 |
USD 24.69 M |
Jan. 14, 2025 | USD 0.39 | -0.45% |
|
Sweden |
|
47 |
USD 24.23 M |
Jan. 14, 2025 | USD 0.25 | -2.43% |
|
Sweden |
|
48 |
USD 24.13 M |
Jan. 14, 2025 | USD 0.25 | 0.32% |
|
Sweden |
|
49 |
USD 23.00 M |
Jan. 14, 2025 | USD 1.87 | 5.71% |
|
Sweden |
|
50 |
USD 20.51 M |
Jan. 14, 2025 | USD 0.84 | -0.17% |
|
Sweden |
The Biotechnology company in Sweden with the highest Market Capitalization is Swedish Orphan Biovitrum AB (publ) (Stockholm Stock Exchange: SOBI.ST) at USD 9.84 B.
The Biotechnology company in Sweden with the lowest Market Capitalization is Ellen AB (publ) (Stockholm Stock Exchange: ELN.ST) at USD 1.01 M.
The top 10 Biotechnology companies in Sweden by Market Capitalization are Swedish Orphan Biovitrum AB (publ), Getinge AB (publ), Vitrolife AB (publ), Bonesupport Holding AB (publ), Elekta AB (publ), Vimian Group AB (publ), BioArctic AB (publ), AddLife AB (publ), Xvivo Perfusion AB (publ) and BioGaia AB (publ).
The bottom 10 Biotechnology companies in Sweden by Market Capitalization are Ellen AB (publ), Qlife Holding AB (publ), Aptahem AB (publ), Qlucore Ab (Publ), Scandinavian Real Heart AB (Publ), Scandinavian ChemoTech AB (publ), CARBIOTIX AB, CombiGene AB (publ), Modus Therapeutics Holding AB (publ) and OncoZenge AB (publ).